XBI 股價展望與 ETF 分析 - 配息·管理費·持股·NAV·RSI·MACD

Q: XBI 有配息嗎？

XBI 的配息殖利率約為 0.35%。

XBI

State Street SPDR S&P Biotech ETF

收盤價 10月30日 4:00 PM ET（韓國 10/31 05:00）

$155.98

-1.81 ▼ -1.15%

10月30日 6:48 PM ET（韓國 10/31 07:48）

$156.00

+0.02 ▲ +0.01%

對稱三角形阻力線 152.62 支撐線 147.56 已結束連續3天同一條線由 AI 繪製的參考線，可能有誤，僅供參考，並非預測。

詳細指標表

Category ⓘ	US Equities - Industry Sector	Expense ⓘ	0.35%	Return% 1Y ⓘ	41.49%	Total Holdings ⓘ	167	Perf Week ⓘ	4.31%	Volume ⓘ	9,076,199
Asset Type ⓘ	Equities (Stocks)	AUM ⓘ	$10.76B	Return% 3Y ⓘ	33.27%	NAV ⓘ	$157.82	Perf Month ⓘ	0.95%	Avg Volume ⓘ	8.88M
ETF Type ⓘ	US Equities	Dividend TTM ⓘ	$0.54 (0.35%)	Return% 5Y ⓘ	5.1%	52W High ⓘ	-8.19%	Perf Quarter ⓘ	5.89%	Rel Volume ⓘ	1.02
Active/Passive ⓘ	Passive	Div Gr. 3/5Y ⓘ	- 9.6%	Return% 10Y ⓘ	10.52%	52W Low ⓘ	46.74%	Perf Half Y ⓘ	19.6%	Prev Close ⓘ	$157.79
IPO ⓘ	2006/2/6	Flows% 1M ⓘ	3.87%	Return% SI ⓘ	11.83%	RSI (14) ⓘ	54.1	Perf YTD ⓘ	27.93%	Price ⓘ	$155.98
Beta ⓘ	0.87	Flows% 3M ⓘ	4.65%	Flows% YTD ⓘ	6.97%	Flows% 1Y ⓘ	11.69%	Perf Year ⓘ	39.38%	Volatility(W/M) ⓘ	2.6% 2.9%
SMA20 ⓘ	2.92%	SMA50 ⓘ	-0.4%	SMA200 ⓘ	10.12%	ATR ⓘ	4.44

ETF 簡介

State Street SPDR S&P Biotech ETFXBI | NYSE | 醫療類股查看深度分析

SPDR S&P Biotech ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Biotechnology Select Industry Index derived from the biotechnology segment of a U.S. total market composite index. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI").

XBI ETF 一覽

0.35% 越低越好

$10.8B 管理資產

167檔

0.35% 半年配

掛牌日 2006年

管理方式追蹤指數

發行公司 State Street

主要持有標的持有 167 檔

前 10 大持股占 基金的 18%

均勻分散在眾多持股中。